Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.

Human pathology - 1 Jun 2011

Baumhoer Daniel, Smida Jan, Specht Katja, Bink Karin, Quintanilla-Martinez Leticia, Rosemann Michael, Siggelkow Heide, Nathrath Walter B J, Atkinson Michael J, Bielack Stefan, Jundt Gernot, Nathrath Michaela

Abstract excerpt

Human epidermal growth factor receptor 2 expression in osteosarcoma and its relationship to prognosis have been the subject of several conflicting reports, most of them relying on immunohistochemical studies. Because the urgent need of prognostic markers and effective new treatment options for osteosarcoma patients, we evaluated the role of human epidermal growth factor receptor 2 in 2 well-characterized sets of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Neoplasms
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to In Situ Hybridization, Fluorescence

Share to Oligonucleotide Array Sequence Analysis

Share to Osteosarcoma

Share to Receptor, ErbB-2

Share to Reverse Transcriptase Polymerase Chain Reaction

Source

Identifiers

PMID: 21292304
DOI: 10.1016/j.humpath.2010.09.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.PMID 21292304Read ↗

Cell Surface Expression of Epidermal Growth Factor Receptor and Her-2 with Nuclear Expression of Her-4 in Primary OsteosarcomaSemantic proximity Read ↗

Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo‐adjuvant chemotherapySemantic proximity Read ↗

<i>HER2</i> Amplification and Overexpression Is Not Present in Pediatric Osteosarcoma: A Tissue Microarray StudySemantic proximity Read ↗

Cell surface receptor expression patterns in osteosarcomaSemantic proximity Read ↗

Meta-analysis of associations of the ezrin gene with human osteosarcoma response to chemotherapy and prognosis.Semantic proximity Read ↗

HER-2/neu and p53 in Osteosarcoma: An Immunohistochemical and Fluorescence In Situ Hybridization AnalysisSemantic proximity Read ↗

Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.Semantic proximity Read ↗

Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma.Semantic proximity Read ↗

Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma.Semantic proximity Read ↗

Essential erbB family phosphorylation in osteosarcoma as a target for CI‐1033 inhibitionSemantic proximity Read ↗

Immunoexpression of Ezrin and CD44 in Patients With OsteosarcomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.